Andy Su Extended Investment Fund extends investment period to 8 years

Radar Finance | Written by Feng Xiuyu | Edited by Li Yihui

On March 6, Blue Star Andy Su Co., Ltd. (Ticker: Andy Su, Stock Code: 600299) announced that its controlling subsidiary, Drakkar Group S.A., participated in the first round of fundraising for the “AVF Professional Private Equity Investment Fund” managed by Seventure Partners on March 20, 2018. The fund primarily invests in areas such as animal health, feed and animal nutrition, and digital agriculture technology. As of the announcement date, Drakkar has contributed 14.112 million euros. The fund has a duration of 10 years (investment period of 5 years, exit period of 5 years).

Recently, with the unanimous approval of all partners, the investment period of the fund has been extended to 8 years, and the exit period adjusted to 2 years, while the duration remains unchanged. The fund has invested in 10 projects, covering fields such as alternative proteins and next-generation biopharmaceutical development. This extension will help enhance research and development capabilities and innovation, aligning with the interests of the partners and not significantly impacting the company’s operations.

According to Tianyancha, Andy Su was established on May 31, 1999, with a registered capital of 2,681,901,273 RMB. The legal representative is Hao Zhigang, and the registered address is 3rd Floor, No. 3079, Chuangye Road, Shangdi Information Industry Base, Haidian District, Beijing. Its main business involves R&D, production, and sales of animal nutrition additives.

Currently, the company’s chairman is Hao Zhigang, the secretary of the board is Cai Yun, with 3,295 employees. The actual controlling shareholder is the State-owned Assets Supervision and Administration Commission of the State Council.

The company holds stakes in 50 subsidiaries, including Adisseo de Mexico S.A. de C.V., Adisseo Nutricion Animal, S.L., Nutriad Nutrio Animal Ltda, Adisseo Eurasie S.A.R.L., Fondoir de Bayonne Blancpignon S.A.S., among others.

In terms of performance, the company’s revenue for 2023, 2024, and 2025 is projected to be 13.184 billion, 15.534 billion, and 17.231 billion RMB, respectively, with year-over-year growth rates of -9.26%, 17.83%, and 10.92%. Net profit attributable to shareholders is expected to be 52.1655 million, 1.204 billion, and 1.155 billion RMB, with YoY growth rates of -95.82%, 2208.66%, and -4.13%. During the same period, the company’s asset-liability ratios are 29.97%, 30.05%, and 28.42%.

Regarding risks, Tianyancha data shows the company has 143 internal Tianyan risks, 840 surrounding risks, 20 historical risks, and 109 warning alerts.